A group of House Democrats is calling on the FDA to explain what the agency is doing to address the shortage of Adderall in the U.S. that was declared exactly one year ago.
In a social media landscape shaped by hashtags, algorithms, and viral posts, nurse leaders must decide: Will they let the narrative spiral, or can they adapt and join the conversation?
...
